ReCor's Renal Denervation System Gets Thumbs Up From FDA Advisory Panel
The panel voted overwhelmingly in favor of safety, but quibbled about efficacy, durability, and benefits versus risk.
Source: tctmd.com
📰 Continued Access Protocol News
Continued Access Protocol News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Continued Access Protocol. Real-time updates on events, politics, business and more.
TransMedics Receives FDA PMA Approval of OCS™ DCD Heart Indication
/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
United States Waleed Hassanein Jacob Schroder Brian Johnston Exchange Commission Duke University Medical Center
Source: prnewswire.com
TransMedics Receives FDA Premarket Approval for OCS™ DCD Heart Indication
TransMedics Group, Inc. (NASDAQ:TMDX) received premarket approval (PMA) from U.S. Food and Drug Administration (FDA) for its OCS™ Heart Syst...
United States Waleed Hassanein Transmedics Group Inc Transmedics Group International Society Of Heart Drug Administration
Source: businessinsider.com